Clinical Characteristics and Survival Analysis in Frequent Alcohol Consumers With COVID-19

Imagem de Miniatura
Arquivos
art_ALBERCA_Clinical_Characteristics_and_Survival_Analysis_in_Frequent_Alcohol_2021.PDF (547.41 KB)
Citações na Scopus
9
Tipo de produção
article
Data de publicação
2021
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
FRONTIERS MEDIA SA
Autores
RIGATO, Paula Ordonhez
Citação
FRONTIERS IN NUTRITION, v.8, article ID 689296, 7p, 2021
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection can generate a systemic disease named coronavirus disease-2019 (COVID-19). Currently, the COVID-19 pandemic has killed millions worldwide, presenting huge health and economic challenges worldwide. Several risk factors, such as age, co-infections, metabolic syndrome, and smoking have been associated with poor disease progression and outcomes. Alcohol drinking is a common social practice among adults, but frequent and/or excessive consumption can mitigate the anti-viral and anti-bacterial immune responses. Therefore, we investigated if patients with self-reported daily alcohol consumption (DAC) presented alteration in the immune response to SARS-CoV-2. We investigated 122 patients with COVID-19 (101 male and 46 females), in which 23 were patients with DAC (18 men and 5 women) and 99 were non-DAC patients (58 men and 41 women), without other infections, neoplasia, or immunodeficiencies. Although with no difference in age, patients with DAC presented an increase in severity-associated COVID-19 markers such as C-reactive protein (CRP), neutrophil count, and neutrophil-to-lymphocyte ratio. In addition, patients with DAC presented a reduction in the lymphocytes and monocytes counts. Importantly, the DAC group presented an increase in death rate in comparison with the non-DAC group. Our results demonstrated that, in our cohort, DAC enhanced COVID-19-associated inflammation, and increased the number of deaths due to COVID-19.
Palavras-chave
COVID-19, SARS-CoV-2, alcohol, consumption, inflammation
URI
https://observatorio.fm.usp.br/handle/OPI/41568
Referências
  1. Alberca GGF, 2021, WORLD J GASTROENTERO, V27, P1255, DOI 10.3748/wjg.v27.i13.1255
  2. Alberca RW, 2020, AM J TROP MED HYG, V103, P2353, DOI 10.4269/ajtmh.20-1185
  3. Alberca RW, 2021, ALLERGY, V76, P963, DOI 10.1111/all.14601
  4. Alberca RW, 2021, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.637627
  5. Alberca RW, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.580677
  6. Ali N, 2020, J INFECT PUBLIC HEAL, V13, P1373, DOI 10.1016/j.jiph.2020.06.021
  7. Anand S, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02147
  8. Bechara RI, 2003, ALCOHOL CLIN EXP RES, V27, P1006, DOI 10.1097/ALC.0000071932.56932.53
  9. Bongiovanni D, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-020-03333-9
  10. Branco ACCC, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.550571
  11. Clugston RD, 2012, NUTRIENTS, V4, P356, DOI 10.3390/nu4050356
  12. Dai MY, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.588553
  13. Dancer RCA, 2015, THORAX, V70, P617, DOI 10.1136/thoraxjnl-2014-206680
  14. de Roux A, 2006, CHEST, V129, P1219, DOI 10.1378/chest.129.5.1219
  15. Garcia LP, 2020, CAD SAUDE PUBLICA, V36, DOI 10.1590/0102-311X00124520
  16. Gibson A, 2008, QJM-INT J MED, V101, P881, DOI 10.1093/qjmed/hcn112
  17. Greenbaum A, 2014, INFECTION, V42, P165, DOI 10.1007/s15010-013-0534-8
  18. Gupta S, 2020, COLORECTAL DIS, V22, P611, DOI 10.1111/codi.15138
  19. Happel Kyle I, 2005, Proc Am Thorac Soc, V2, P428, DOI 10.1513/pats.200507-065JS
  20. Jacobs M, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.02378-2020
  21. Jakhmola S, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00984
  22. Jerrells TR, 2007, ALCOHOL, V41, P357, DOI 10.1016/j.alcohol.2007.07.001
  23. Khan KN, 2000, ALCOHOL ALCOHOLISM, V35, P286, DOI 10.1093/alcalc/35.3.286
  24. Langford BJ, 2020, CLIN MICROBIOL INFEC, V26, P1622, DOI 10.1016/j.cmi.2020.07.016
  25. Li XG, 2020, J MED VIROL, V92, P602, DOI [10.1016/j.jaci.2020.04.006, 10.1002/jmv.25731]
  26. Lian JS, 2020, AGING-US, V12, P13849, DOI 10.18632/aging.103582
  27. Lieber CS, 2000, ANNU REV NUTR, V20, P395, DOI 10.1146/annurev.nutr.20.1.395
  28. Lippai D, 2014, ALCOHOL CLIN EXP RES, V38, P2217, DOI 10.1111/acer.12483
  29. Litwinowicz K, 2020, AM J DRUG ALCOHOL AB, V46, P4, DOI 10.1080/00952990.2019.1669629
  30. Liu JH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241659
  31. Liu JY, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02374-0
  32. Lombardi A, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.560330
  33. Marshall SA, 2017, J NEUROIMMUNE PHARM, V12, P249, DOI 10.1007/s11481-016-9709-2
  34. Middleton EA, 2020, BLOOD, V136, P1169, DOI 10.1182/blood.2020007008
  35. Monnig MA, 2017, AM J DRUG ALCOHOL AB, V43, P7, DOI 10.1080/00952990.2016.1211667
  36. OKUNO F, 1986, ALCOHOL, V3, P357, DOI 10.1016/0741-8329(86)90053-4
  37. Pasala S, 2015, ALCOHOL RES-CURR REV, V37, P185
  38. Penkert Rhiannon R, 2021, J Infect Dis, V223, P1806, DOI 10.1093/infdis/jiaa597
  39. Qin C, 2020, CLIN INFECT DIS, V71, P762, DOI 10.1093/cid/ciaa248
  40. Qin S, 2021, HUM IMMUNOL, V82, P170, DOI 10.1016/j.humimm.2020.12.010
  41. Radujkovic A, 2020, NUTRIENTS, V12, DOI 10.3390/nu12092757
  42. Rodriguez L, 2020, CELL REP MED, V1, DOI 10.1016/j.xcrm.2020.100078
  43. Saitz R, 1997, ARCH INTERN MED, V157, P1446, DOI 10.1001/archinte.157.13.1446
  44. Saltzman ET, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00061
  45. Sarkar D., 2015, ALCOHOL RES-CURR REV, V298, P543, DOI [10.1136/bmj.298.6673.543, DOI 10.1136/BMJ.298.6673.543]
  46. Schmidt R, 2004, EUR RESPIR J, V24, P994, DOI 10.1183/09031936.04.00120703
  47. Sharifpour M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242400
  48. Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070
  49. Szabo G, 1998, ALCOHOL CLIN EXP RES, V22, p216S, DOI 10.1111/j.1530-0277.1998.tb04005.x
  50. Wang L, 2020, MED MALADIES INFECT, V50, P332, DOI 10.1016/j.medmal.2020.03.007
  51. WHO Coronavirus Disease (COVID-19), COR DIS COVID 19 DAS
  52. Wyatt TA, 2019, ALCOHOL, V80, P17, DOI 10.1016/j.alcohol.2018.07.010
  53. Yildiz H, 2021, INFECT DIS-NOR, V53, P78, DOI 10.1080/23744235.2020.1823469
  54. Zhang BC, 2020, FRONT MOL BIOSCI, V7, DOI 10.3389/fmolb.2020.00157
  55. Zhong R, 2021, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.623498
  56. Zuo T, 2020, GASTROENTEROLOGY, V159, P944, DOI 10.1053/j.gastro.2020.05.048

Coleções
Artigos e Materiais de Revistas Científicas - FM/MPT
Artigos e Materiais de Revistas Científicas - COVID-19
Artigos e Materiais de Revistas Científicas - FM/MDT
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/56
Artigos e Materiais de Revistas Científicas - ODS/03